Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

BUY
$20.49 - $39.72 $78,702 - $152,564
3,841 Added 36.91%
14,248 $306,000
Q1 2022

May 13, 2022

SELL
$28.19 - $46.6 $76,535 - $126,519
-2,715 Reduced 20.69%
10,407 $385,000
Q4 2021

Feb 10, 2022

BUY
$41.2 - $73.6 $71,646 - $127,990
1,739 Added 15.28%
13,122 $597,000
Q3 2021

Nov 15, 2021

BUY
$59.15 - $91.99 $78,906 - $122,714
1,334 Added 13.27%
11,383 $721,000
Q2 2021

Aug 16, 2021

BUY
$63.02 - $95.11 $70,834 - $106,903
1,124 Added 12.59%
10,049 $920,000
Q1 2021

May 17, 2021

BUY
$57.62 - $95.6 $514,258 - $853,230
8,925 New
8,925 $608,000

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $1.15B
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.